|Prostate Cancer||53||United Kingdom||2015||currently in treatment|
Jan, Prostate Cancer
|53||United Kingdom||2015||currently in treatment|
In 2015 the patient was diagnosed for a prostate cancer stage IV.
Prostate cancer with presence of bone metastases
Biomarkers already tested:
– 2015 Bicalutamide
– 2015 LHRH agonist
– 2016 radical prostatectomy
– 2017 Zoladex
– Variants found in FANCA and CYP2D6 (NGS)
– STK11 / P4EBP1 : high expression (IHC)
– PTEN negative
– Approved for prostate cancer : taxane-based chemotherapies
– Strong evidence for responsiveness to mTOR inhibitors
Patient just started treatment.